Sign in:
Email
 Password  save:
  
 Company Reports 
 

   
My Recent Searches
  Help
 
   
 
 
   Get Roster for :  
Lenz Therapeutics (LENZ)  
$18.41 0.23 (1.23%) as of 4:30 Wed 5/22


Download
   
  Company Roster

Total Insiders  : 16  
Total Direct Shares :
22,539,553
Total Indirect Shares :
19,191,869
 
% Held by Insiders:
88.27%
 
7 other people own 
 $19,141,926 Lehrer-Graiwer Joshua
 $21,386,345 Versant Ventures Vii Gp-G...
 $38,683,074 Porteus Matthew
 $64,960,219 Versant Vantage Ii Gp-Gp,...
 $270,781,607  
 
Filer's Name Relation Direct Date   Direct Shares Indirect Date Indirect Shares
   Chevallard Daniel R. Chief Financial Officer 2024-05-14 3,188 2024-05-14 0
   Mccollum James W Director 2024-05-13 95,034 2024-05-13 525,565
   Shah Rajeev M. Director, 10% Owner 2024-03-21 0 2024-03-21 694,755
   Versant Ventures Vii Gp-Gp, Llc 2024-03-21 2,101,199 2024-03-21 2,440,951
   Odrich Marc Chief Medical Officer 2024-03-21 99,599 2024-03-21 0
   Gutry Phil CHIEF BUSINESS OFFICER 2022-04-11 299,941 0
   Karsen Perry A Director 2021-06-29 164,034 0
   Shah Smital Director 2021-06-29 0 2021-06-29 5,882
   Jimenez Joseph Director 2021-06-29 161,941 0
   Akkaraju Srinivas 10% Owner 2021-06-29 0 2022-04-12 8,497,067
   Versant Vantage Ii Gp-Gp, Llc 10% Owner 2021-06-29 14,708,398 2021-06-29 1,707,719
   Lehrer-Graiwer Joshua PRESIDENT AND CEO, Director 2021-06-29 1,161,670 0
   Stultz Katherine V CHIEF OPERATING OFFICER 2021-06-29 216,020 0
   Porteus Matthew Director 2021-06-24 3,528,529 0
   Jerel Davis Director, 10% Owner 0 2021-06-29 1,707,719
   Chimera Investment Llc 10% Owner 0 2024-03-21 3,612,211
16 Records found